F.D.A.’s Approval of Drug for Autism Upends Review Process

By Christina Jewett from NYT Health https://ift.tt/kpAzsOe
via IFTTT
Health
Intellectual Disabilities, Regulation and Deregulation of Industry, Disabilities, Autism, United States Politics and Government, Generic Brands and Products, Labeling and Labels (Product), Folic Acid, Doctors
New York Times
September 24, 2025 at 01:30AM